168 related articles for article (PubMed ID: 6607074)
1. [New preparation method of C1 esterase for the dosage of its plasma inhibitor].
Gozin D; Ollier-Hartmann MP; Lerable J; Hartmann L; Soulier JP
Biomed Pharmacother; 1983; 37(5):228-30. PubMed ID: 6607074
[TBL] [Abstract][Full Text] [Related]
2. [Current diagnostic possibilities in hereditary angioedema and acquired angioedema].
Dick W; Cullmann W
Immun Infekt; 1985 May; 13(3):113-8. PubMed ID: 3924818
[TBL] [Abstract][Full Text] [Related]
3. [Hereditary angioneurotic edema: a molecular disease caused by a defect in the O-glycosylation of C1 esterase inhibitor (C1-INH)].
Ollier-Hartmann MP; Strecker G; Montreuil J; Hartmann L
C R Acad Sci III; 1984; 299(16):667-9. PubMed ID: 6440668
[TBL] [Abstract][Full Text] [Related]
4. A kinetic test for the assay of the C1 esterase-inhibitor.
Schena FP; Manno C; D'Agostino R; Bruno G; Cramarossa F; Bonomo L
J Clin Chem Clin Biochem; 1980 Jan; 18(1):17-21. PubMed ID: 6965706
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
Jackson J; Sim RB; Whaley K; Feighery C
J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
[TBL] [Abstract][Full Text] [Related]
6. [Study by means of enzymatic and immunochemical determination of Cl esterase inhibitor in 59 patients with hereditary angioneurotic edema].
Agostoni A; Marasini B; Cicardi M; Martignoni G; Brenna O
Boll Ist Sieroter Milan; 1977 Mar; 56(1):22-8. PubMed ID: 861073
[TBL] [Abstract][Full Text] [Related]
7. [Anomaly of the polypeptide and oligosaccharide chains of alpha-2-neuraminoglycoprotein in various types of hereditary angioneurotic edema].
Ollier-Hartmann MP; Hartmann L
C R Seances Acad Sci D; 1980 May; 290(18):1201-4. PubMed ID: 6772326
[TBL] [Abstract][Full Text] [Related]
8. C1 esterase inhibitor: new preparation. A major advance in emergency treatment of hereditary angioneurotic oedema.
Prescrire Int; 2001 Jun; 10(53):67-70. PubMed ID: 11718165
[TBL] [Abstract][Full Text] [Related]
9. A new simple method for determination of C1-esterase inhibitor activity in plasma.
Wiman B; Nilsson T
Clin Chim Acta; 1983 Mar; 128(2-3):359-66. PubMed ID: 6602012
[TBL] [Abstract][Full Text] [Related]
10. Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.
Nilsson T; Bäck O
Clin Exp Immunol; 1985 Apr; 60(1):178-82. PubMed ID: 3874014
[TBL] [Abstract][Full Text] [Related]
11. C1-inhibitor--biochemical properties and clinical applications.
Al-Abdullah IH; Greally J
Crit Rev Immunol; 1985; 5(4):317-30. PubMed ID: 3899511
[TBL] [Abstract][Full Text] [Related]
12. Interactions of plasma kallikrein and C1-s with normal and dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema: analytic gel studies.
Donaldson VH; Wagner CJ; Tsuei B; Kindness G; Bing DH; Harrison RA; Rosen FS
Blood; 1987 Apr; 69(4):1096-101. PubMed ID: 3493816
[TBL] [Abstract][Full Text] [Related]
13. A sensitive method to assay blood complement C1- inhibitor activity.
Drouet C; Alibeu C; Ponard D; Arlaud GJ; Colomb MG
Clin Chim Acta; 1988 May; 174(2):121-30. PubMed ID: 3260154
[TBL] [Abstract][Full Text] [Related]
14. Distinction between hereditary and acquired angioneurotic oedema according to the complement system.
Brecy H; Hartmann L
Biomedicine; 1975 Oct; 23(8):328-34. PubMed ID: 1231927
[TBL] [Abstract][Full Text] [Related]
15. [The molecular expression of C1 esterase inhibitor in hereditary angioneurotic oedema. Study of 32 families (author's transl)].
Ollier MP; Hartmann L; Brecy H
Nouv Presse Med; 1978 Sep; 7(33):2933-8. PubMed ID: 724440
[TBL] [Abstract][Full Text] [Related]
16. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
[TBL] [Abstract][Full Text] [Related]
17. [A case report of hereditary angioedema and studies on the serum components of complement, C1-inactivator and proteinase inhibitors during edema attack].
Mikami A; Kohno M
Hokkaido Igaku Zasshi; 1987 May; 62(3):497-500. PubMed ID: 3610041
[TBL] [Abstract][Full Text] [Related]
18. A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.
Bianchino AC; Poon PH; Schumaker VN
J Immunol; 1988 Dec; 141(11):3930-6. PubMed ID: 3183385
[TBL] [Abstract][Full Text] [Related]
19. Serum C1-esterase inhibitor (C1INH) levels in normal adults.
Ongaro G; Calabrò A; Panunzio MT
Quad Sclavo Diagn; 1982 Mar; 18(1):104-13. PubMed ID: 6818608
[No Abstract] [Full Text] [Related]
20. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
Giclas PC
J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
